Kwok-Yung Yuen Selected Research

Kwok-Yung Yuen Research Topics

Disease

170	Infections 04/2024 - 07/2002
88	COVID-19 04/2024 - 01/2020
57	Human Influenza (Influenza) 12/2023 - 06/2005
32	Virus Diseases (Viral Diseases) 03/2024 - 01/2005
25	Pneumonia (Pneumonitis) 05/2023 - 08/2003
19	Severe Acute Respiratory Syndrome 12/2023 - 06/2004
15	Influenza in Birds (Avian Flu) 11/2023 - 06/2006
14	Bacteremia 05/2022 - 07/2002
12	Inflammation (Inflammations) 04/2024 - 04/2002
10	Body Weight (Weight, Body) 01/2022 - 06/2008
9	Coinfection 10/2023 - 01/2003
9	Tuberculosis (Tuberculoses) 11/2022 - 02/2004
7	Reinfection 03/2023 - 08/2010
6	Fever (Fevers) 03/2024 - 06/2013
6	Hepatitis 10/2022 - 02/2007
6	Melioidosis 02/2016 - 04/2001
5	Necrosis 12/2023 - 09/2003
5	Breakthrough Infections 12/2023 - 01/2022
5	Weight Loss (Weight Reduction) 10/2022 - 12/2016
5	Neoplasms (Cancer) 04/2021 - 01/2012
5	Zika Virus Infection 09/2017 - 12/2016
5	Communicable Diseases (Infectious Diseases) 06/2015 - 01/2004
5	Aspergillosis 06/2015 - 06/2002
4	Obesity 03/2023 - 04/2013
4	Scarlet Fever 05/2022 - 08/2012
4	Wounds and Injuries (Trauma) 12/2016 - 09/2003
3	Adenocarcinoma of Lung 12/2022 - 06/2013
3	Staphylococcal Infections 08/2021 - 01/2017
3	Cytokine Release Syndrome 10/2020 - 06/2008
3	Viremia 12/2018 - 03/2010
3	Diarrhea 10/2016 - 04/2011
3	Lung Diseases (Lung Disease) 04/2016 - 02/2004

Drug/Important Bio-Agent (IBA)

62	VaccinesIBA 04/2024 - 07/2002
49	Antiviral Agents (Antivirals)IBA 04/2024 - 06/2008
43	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2002
30	CytokinesIBA 04/2024 - 03/2010
25	AntigensIBA 03/2023 - 07/2002
23	Neutralizing AntibodiesIBA 12/2023 - 01/2006
22	AntibodiesIBA 11/2022 - 06/2002
19	ChemokinesIBA 12/2023 - 03/2010
19	Immunoglobulin G (IgG)IBA 09/2023 - 12/2004
13	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2004
13	Anti-Bacterial Agents (Antibiotics)IBA 05/2023 - 12/2006
13	EnzymesIBA 11/2022 - 06/2004
12	Messenger RNA (mRNA)IBA 12/2023 - 12/2013
11	RNA (Ribonucleic Acid)IBA 09/2023 - 01/2006
11	Peptides (Polypeptides)IBA 11/2022 - 12/2004
10	Hemagglutinins (Hemagglutinin)IBA 01/2020 - 05/2010
9	Monoclonal AntibodiesIBA 10/2023 - 06/2004
9	16S Ribosomal RNAIBA 07/2012 - 01/2002
8	NucleoproteinsIBA 12/2023 - 05/2009
8	ImmunosorbentsIBA 11/2022 - 07/2004
8	LipidsIBA 01/2022 - 05/2015
8	Nucleocapsid ProteinsIBA 10/2021 - 07/2004
7	N-(2-cyanoethylene)urea (BA 1)IBA 12/2023 - 01/2022
7	InterferonsIBA 10/2023 - 03/2016
6	EpitopesIBA 12/2023 - 02/2008
6	BNT162 VaccineIBA 03/2023 - 12/2021
6	Immunoglobulin M (IgM)IBA 01/2021 - 07/2005
6	Oseltamivir (Tamiflu)FDA Link 01/2017 - 06/2008
5	Neuraminidase (Sialidase)IBA 11/2023 - 06/2008
5	sinovac COVID-19 vaccineIBA 03/2023 - 12/2021
5	Influenza Vaccines (Influenza Vaccine)FDA Link 08/2021 - 07/2012
5	Phosphotransferases (Kinase)IBA 01/2021 - 07/2015
5	Interferon-gamma (Interferon, gamma)IBA 01/2017 - 09/2003
4	C-Reactive ProteinIBA 03/2024 - 01/2020
4	Interleukin-6 (Interleukin 6)IBA 12/2023 - 09/2003
4	Immunoglobulin A (IgA)IBA 12/2023 - 01/2008
4	N-methyl-valyl-amiclenomycin (BA 2)IBA 09/2023 - 01/2022
4	Carbapenems (Carbapenem Antibiotics)IBA 06/2023 - 10/2012
4	mRNA VaccinesIBA 03/2023 - 12/2021
4	COVID-19 VaccinesIBA 03/2023 - 01/2022
4	remdesivirIBA 01/2023 - 10/2020
4	Immunosuppressive Agents (Immunosuppressants)IBA 10/2022 - 06/2015
4	AerosolsIBA 01/2022 - 11/2020
4	DNA VaccinesIBA 01/2022 - 07/2002
4	AcidsIBA 11/2021 - 04/2002
4	Imiquimod (Aldara)FDA LinkGeneric 01/2021 - 04/2014
4	Amino Acids FDA Link 12/2020 - 04/2001
4	Interferon Type IIBA 05/2017 - 06/2009
4	Immunologic Factors (Immunomodulators)IBA 01/2016 - 06/2008
3	MacrolidesIBA 03/2024 - 11/2009
3	Broadly Neutralizing AntibodiesIBA 12/2023 - 01/2013
3	Viral AntigensIBA 09/2023 - 01/2019
3	Cephalosporins (Cephalosporin Antibiotics)IBA 08/2022 - 02/2005
3	Viral ProteinsIBA 12/2021 - 09/2006
3	Glycoproteins (Glycoprotein)IBA 10/2021 - 01/2006
3	Toll-Like Receptor 7IBA 01/2021 - 04/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 07/2002
3	Oxygen (Dioxygen)IBA 12/2020 - 03/2010
3	Nucleic AcidsIBA 01/2020 - 11/2014
3	ElementsIBA 01/2019 - 08/2012
3	Zanamivir (Relenza)FDA Link 09/2018 - 06/2008
3	AutoantibodiesIBA 03/2016 - 07/2010

Therapy/Procedure

35	Therapeutics 04/2024 - 03/2002
6	Liver Transplantation 12/2018 - 01/2008
4	Length of Stay 01/2020 - 01/2004
4	Transplantation 01/2019 - 11/2014
3	Aftercare (After-Treatment) 05/2023 - 02/2016
3	Patient Admission (Patient Admissions) 05/2022 - 05/2017